SEVERE HYPONATREMIA, EPISTAXIS, AND FLUOXETINE

Authors

  • Tezcan Kaya Sakarya University Faculty of Medicine, Sakarya
  • Murat Yücel Sakarya University Faculty of Medicine, Sakarya
  • Özden Eraslan Sakarya University Faculty of Medicine, Sakarya
  • Hakan Cinemre Department of Ear Nose and Throat, Sakarya University Faculty of Medicine, Sakarya
  • Ali Tamer Department of Ear Nose and Throat, Sakarya University Faculty of Medicine, Sakarya

Abstract

Hyponatremia is one of the most common electrolyte abnormalities and can be life threatening. Fluoxetine is a serotonin reuptake inhibitor and may rarely cause hyponatremia. Furthermore, fluoxetine may rarely increase the risk of bleeding events. We report a 66-year old woman who presented with severe hyponatremia and epistaxis associated with the use of fluoxetine.

References

Zahajszky J, Rosenbaum JF, Tollefson GD. Fluoxetine. In: American Psychiatric Publishing Textbook of Psychopharmacology, 4th ed, American Psychiatric Publishing, Inc, Washington, DC 2009. p.289.

Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, et al. Clinical practice guideline on diagnosis and treatment of hyponatremia. Nephrol Dial Transplant 2014;29 Suppl 2:i1–39.

Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med 2000;342(21):1581–9.

Labbate LA, Fava M, Rosenbaum JF, Arana GW. Drugs for the treatment of depression. In: Handbook of Psychiatric Drug Therapy, 6th ed, Lippincott Williams & Wilkins, Philadelphia, PA 2010. p.54.

de Abajo FJ, Rodríguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 1999;319(7217):1106–9.

Serebruany VL. Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something? Am J Med 2006;119(2):113–6.

Hu XH, Bull SA, Hunkeler EM, Ming E, Lee JY, Fireman B, et al. Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. J Clin Psychiatry 2004;65(7):959–65.

Janicic N, Verbalis JG. Evaluation and management of hypo-osmolality in hospitalized patients. Endocrinol Metab Clin North Am 2003;32(2):459–81.

Wilkinson TJ, Begg EJ, WinterAC, Sainsbury R. Incidence and risk factors for hyponatremia following treatment with fluoxetine or paroxetine in elderly people. Br J Clin Pharmacol 1999;47(2):211–7.

Li N, Wallén NH, Ladjevardi M, Hjemdahl P. Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis 1997;8(8):517–23.

Published

2016-03-10